Detalhe da pesquisa
1.
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Cancer
; 130(9): 1693-1701, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165808
2.
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
Cancer
; 130(4): 541-552, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843249
3.
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.
Cancer
; 129(19): 2966-2974, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246414
4.
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
Oncologist
; 27(4): 255-265, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274704
5.
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma.
J Neurooncol
; 156(3): 541-549, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094201
6.
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer.
Support Care Cancer
; 30(9): 7431-7438, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622149
7.
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Cancer
; 127(16): 3019-3028, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826761
8.
Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect.
Cancer Immunol Immunother
; 70(5): 1203-1211, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123755
9.
Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients.
Chemotherapy
; 66(4): 107-112, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34350854
10.
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
Cancer
; 126(17): 4002-4012, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584426
11.
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
BMC Cancer
; 20(1): 727, 2020 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758163
12.
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors.
BMC Ophthalmol
; 20(1): 19, 2020 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918686
13.
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.
Int J Cancer
; 145(9): 2433-2439, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30807641
14.
Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology.
Tumour Biol
; 36(2): 1073-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25326808
15.
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
J Transl Med
; 12: 299, 2014 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25343854
16.
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal Cancer.
Chemotherapy
; 60(2): 73-80, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25471123
17.
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.
Cancer Res Treat
; 56(1): 61-69, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37448121
18.
Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAFV600E-Mutated Thyroid Cancer.
Cancer Res Treat
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453274
19.
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis.
Lung Cancer
; 190: 107536, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493759
20.
Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.
Cancer Res Treat
; 56(2): 567-579, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846467